cell and gene therapies | pharmaphorum

Sunday 1 February 2026

cell and gene therapies

News

Bayer CoLab

Bayer adds a new life science incubator in China

Bayer’s network of Co.Lab life sciences incubators has expanded once again with the announcement of a new site in Shanghai, China, that will focus on oncology cell and gen

R&D

Stefan Woxström and Stefan Vlachos

A World Without Disease – AstraZeneca and the Health Works I...

Ahead of the inaugural World Without Disease Summit on Wednesday 21st June, pharmaphorum spoke with the event’s two speakers from AstraZeneca, Stefan Woxström, SVP Europe and Canada, and Stefan Vlachos, Head of Health Works

News

Bayer Co.Lab

Bayer adds US life sciences incubator in Cambridge

Bayer has formally opened a new life sciences incubator in Cambridge, Massachusetts, that will focus on cell and gene therapies (CGT).

Market Access

Navigating Routes to Commercial Excellence in Cell and Gene Therapy

Sponsored

Navigating Routes to Commercial Excellence in Cell and Gene ...

'Navigating Routes to Commercial Success in Cell and Gene Therapy', authored by Franjo Hanzl, VP, Business Development, Commercial at EVERSANA, Dr.

R&D

pharmaphorum Health Innovators with CSL

CSL reflects on its future, past as new R&D lab opens

Last month, global pharmaceutical maker CSL cut the ribbon on a brand-new research facility in Waltham, Massachusetts, wher

R&D

Allogeneic therapies: The future of cancer treatment?

Allogeneic therapies: The future of cancer treatment?

Allogeneic therapies could provide an answer to some of the drawbacks of autologous therapies.